RERE, arginine-glutamic acid dipeptide repeats, 473

N. diseases: 215; N. variants: 48
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs4908760
rs4908760
Entrez Id: 473
Gene Symbol: RERE
RERE
CUI: C0042900
Disease:
Vitiligo
0.800 GeneticVariation GWASDB Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. 22561518 2012
dbSNP: rs4908760
rs4908760
Entrez Id: 473
Gene Symbol: RERE
RERE
CUI: C0042900
Disease:
Vitiligo
G 0.800 GeneticVariation GWASCAT Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. 20410501 2010
dbSNP: rs4908760
rs4908760
Entrez Id: 473
Gene Symbol: RERE
RERE
CUI: C0042900
Disease:
Vitiligo
G 0.800 GeneticVariation GWASDB Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. 20410501 2010
dbSNP: rs301807
rs301807
Entrez Id: 473;102724552
Gene Symbol: RERE;RERE-AS1
RERE;RERE-AS1
CUI: C0042900
Disease:
Vitiligo
A 0.700 GeneticVariation GWASCAT Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. 27723757 2016
dbSNP: rs301819
rs301819
Entrez Id: 473
Gene Symbol: RERE
RERE
CUI: C0042900
Disease:
Vitiligo
0.700 GeneticVariation GWASDB Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset. 21326295 2011